GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Holdco Nuvo Group DG Ltd (NAS:NUVO) » Definitions » ROIC %

Holdco Nuvo Group DG (Holdco Nuvo Group DG) ROIC % : -49.53% (As of Dec. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Holdco Nuvo Group DG ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Holdco Nuvo Group DG's annualized return on invested capital (ROIC %) for the quarter that ended in Dec. 2023 was -49.53%.

As of today (2024-05-27), Holdco Nuvo Group DG's WACC % is 8.98%. Holdco Nuvo Group DG's ROIC % is -49.53% (calculated using TTM income statement data). Holdco Nuvo Group DG earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Holdco Nuvo Group DG ROIC % Historical Data

The historical data trend for Holdco Nuvo Group DG's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Holdco Nuvo Group DG ROIC % Chart

Holdco Nuvo Group DG Annual Data
Trend Dec21 Dec22 Dec23
ROIC %
-98.87 -66.75 -49.53

Holdco Nuvo Group DG Semi-Annual Data
Dec21 Dec22 Dec23
ROIC % -98.87 -66.75 -49.53

Competitive Comparison of Holdco Nuvo Group DG's ROIC %

For the Medical Devices subindustry, Holdco Nuvo Group DG's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Holdco Nuvo Group DG's ROIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Holdco Nuvo Group DG's ROIC % distribution charts can be found below:

* The bar in red indicates where Holdco Nuvo Group DG's ROIC % falls into.



Holdco Nuvo Group DG ROIC % Calculation

Holdco Nuvo Group DG's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2023 is calculated as:

ROIC % (A: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2022 ) + Invested Capital (A: Dec. 2023 ))/ count )
=-16.633 * ( 1 - 2.99% )/( (36.534 + 28.618)/ 2 )
=-16.1356733/32.576
=-49.53 %

where

Holdco Nuvo Group DG's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Dec. 2023 is calculated as:

ROIC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2022 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=-16.633 * ( 1 - 2.99% )/( (36.534 + 28.618)/ 2 )
=-16.1356733/32.576
=-49.53 %

where

Note: The Operating Income data used here is one times the annual (Dec. 2023) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Holdco Nuvo Group DG  (NAS:NUVO) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Holdco Nuvo Group DG's WACC % is 8.98%. Holdco Nuvo Group DG's ROIC % is -49.53% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Holdco Nuvo Group DG ROIC % Related Terms

Thank you for viewing the detailed overview of Holdco Nuvo Group DG's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Holdco Nuvo Group DG (Holdco Nuvo Group DG) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
94 Yigal Alon Street, Alon Tower 1, Tel Aviv, ISR, 6789155
Holdco Nuvo Group DG Ltd is a women's health and connected pregnancy care company and has developed INVU by Nuvo, an FDA-cleared, prescription-initiated, remote pregnancy monitoring platform that enables the delivery of remote non-stress tests and maternal and fetal heart rate monitoring, helping expectant mothers adhere to their prescribed care plan. It is leading the transformation from a world where pregnancy care is limited by outdated technology and barriers to accessing care to a world where data-driven, clinically relevant, actionable insights can be accessed both at home and in the clinic. INVU is composed of a hardware component (wearable), with digital signal processing and cloud analytics, and interfaces for every participant involved in pregnancy care.

Holdco Nuvo Group DG (Holdco Nuvo Group DG) Headlines